'Pemetrexed' presentation slideshows

All questions at a glance: please click on question to review

Questions and answers about PARAMOUNT: phase III study of pemetrexed continuation maintenance therapy in advanced non-squamous NSCLC. All questions at a glance: please click on question to review. 2. 3. 1.

458 views • 33 slides

357 views • 18 slides

Use of Pemetrexed in Mesothelioma

445 views • 12 slides

C.P. Belani 1 , T. Brodowicz 2 , P. Peterson 3 , W. John 3 , G. Scagliotti 4

C.P. Belani 1 , T. Brodowicz 2 , P. Peterson 3 , W. John 3 , G. Scagliotti 4 1 Penn State Cancer Institute, Hershey, PA USA; 2 Medical University, Vienna, Austria; 3 Eli Lilly and Co., IN, USA; 4 University of Torino, Orbassano, Italy.

189 views • 9 slides

C.P. Belani 1 , T. Brodowicz 2 , P. Peterson 3 , W. John 3 , G. Scagliotti 4

C.P. Belani 1 , T. Brodowicz 2 , P. Peterson 3 , W. John 3 , G. Scagliotti 4 1 Penn State Cancer Institute, Hershey, PA USA; 2 Medical University, Vienna, Austria; 3 Eli Lilly and Co., IN, USA; 4 University of Torino, Orbassano, Italy.

90 views • 9 slides

Mode of Action

Mode of Action. 5FU. MTX. Pemetrexed. TS Thymidylate synthase DHFR Dihydrofolate reductase GARFT Glycinamide ribonucleotide formyltransferase. Multi target antifolate. Folic acid. GAR = glycinamide ribotide. Dihydrofolate reductase. Dihydro-folate (DHF).

1.15k views • 3 slides

Pemetrexed, sold under brand name Alimta by Eli Lilly and Company is a chemotherapy drug indicated for the treatment of pleural mesothelioma and non-small cell lung cancer.

49 views • 3 slides

Pemetrexed Market: What A Mistake!

Pemetrexed disodium is a chemotherapy drug used in the treatment of malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC). The generic version of the drug is named as pemetrexed. Currently, it is available in powder form, which is then converted to solution for intravenous infusion.

82 views • 3 slides

Malignant Pleural Mesothelioma :

Malignant Pleural Mesothelioma : ALIMTA in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery. Non-small cell lung cancer :

266 views • 1 slides